No Data
HAITONG SEC: The trend of moderate price reductions in the centralized procurement of Traditional Chinese Medicine varieties continues, and the domestic Pharmaceutical industry is expected to usher in a wave of mergers and acquisitions.
HAITONG SEC released a Research Report stating that the gentle trend of price reduction for Traditional Chinese Medicine varieties continues.
China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Hong Kong's Department of Health: To develop Hong Kong into a gateway for the internationalization of traditional Chinese medicine and Chinese herbal medicine.
Secretary for Food and Health of the Hong Kong Special Administrative Region, Dr. Constance Chan, stated that in order to promote the standardization and internationalization of traditional chinese medicine, Hong Kong aims to become a gateway for the internationalization of traditional chinese medicine.
China Shineway Pharmaceutical Group Limited (HKG:2877) Top Key Executive Zhenjiang Li's Holdings Dropped 8.0% in Value as a Result of the Recent Pullback
shineway pharm (02877) had a turnover of 2.887 billion yuan in the first three quarters, a year-on-year decrease of 16.9%.
Shineway Pharm (02877) announced that as of September 30, 2024, the nine months ended have not been reviewed by auditors...
Express News | China Shineway Pharmaceutical - Nine Months Turnover RMB 2,887 Mln Down 16.9%
China Shineway Pharmaceutical Group Limited's (HKG:2877) 30% Share Price Surge Not Quite Adding Up
